Literature DB >> 19629483

Tumor-selective cytotoxicity of benzo[c]phenanthridine derivatives from Toddalia asiatica Lam.

Hironori Iwasaki1, Takafumi Okabe, Kensaku Takara, Takayoshi Toda, Masayuki Shimatani, Hirosuke Oku.   

Abstract

PURPOSE: To develop a novel anti-cancer drug of low side effect against lung adenocarcinoma, the authors screened the bioresources of Okinawa Island, Japan. The medicinal plant Toddalia asiatica Lam. contained three benzo[c]phenanthridine derivatives: dihydronitidine (DHN), nitidine (NTD) and demethylnitidine (DMN). Of the three derivatives, DHN had been shown to selectively inhibit the growth of cancer cells in our previous study. Because of similar molecular topology of NTD or DMN to DHN, it can be expected that NTD and DMN also show selective cytotoxicity. The aim of the present study was therefore to examine the selective cytotoxicity of these two compounds in vitro and in vivo.
METHODS: Benzo[c]phenanthridine derivatives were isolated from T. asiatica Lam., and their chemical structures were identified by interpretation of NMR and MS spectrum. Of the isolated compounds, NTD and DMN were evaluated for cytotoxicity in vitro or in vivo.
RESULTS: NTD as well as DHN selectively reduced the growth of murine and human lung adenocarcinoma in vitro with selective intracellular accumulation. NTD has also been proven to be highly effective in vivo to inhibit the growth of both murine and human lung adenocarcinoma in a subcutaneous xenograft model without any deteriorating side effect. In contrast, DMN had no selective cytotoxicity suggesting that 8-methoxy group of NTD is the critical structural feature for the selective cytotoxicity.
CONCLUSIONS: This study thus proves the effectiveness of benzo[c]phenanthridine derivatives as anti-cancer agent in vivo for the first time, and discusses the mechanisms responsible for the selective cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19629483     DOI: 10.1007/s00280-009-1077-7

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  7 in total

Review 1.  Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine.

Authors:  Nianzhi Chen; Yulin Qi; Xiao Ma; Xiaolin Xiao; Qingsong Liu; Ting Xia; Juyi Xiang; Jinhao Zeng; Jianyuan Tang
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

2.  A phenanthrene derived PARP inhibitor is an extra-centrosomes de-clustering agent exclusively eradicating human cancer cells.

Authors:  Asher Castiel; Leonid Visochek; Leonid Mittelman; Françoise Dantzer; Shai Izraeli; Malka Cohen-Armon
Journal:  BMC Cancer       Date:  2011-09-26       Impact factor: 4.430

3.  Nitidine chloride inhibits hepatic cancer growth via modulation of multiple signaling pathways.

Authors:  Jiumao Lin; Aling Shen; Hongwei Chen; Jun Liao; Teng Xu; Liya Liu; Jing Lin; Jun Peng
Journal:  BMC Cancer       Date:  2014-09-30       Impact factor: 4.430

4.  Tumor-Selective Cytotoxicity of Nitidine Results from Its Rapid Accumulation into Mitochondria.

Authors:  Hironori Iwasaki; Masashi Inafuku; Naoyuki Taira; Seikoh Saito; Hirosuke Oku
Journal:  Biomed Res Int       Date:  2017-04-26       Impact factor: 3.411

5.  Cell Cycle Arrest and Apoptosis in HT-29 Cells Induced by Dichloromethane Fraction From Toddalia asiatica (L.) Lam.

Authors:  Xun Li; Zidong Qiu; Qinghao Jin; Guilin Chen; Mingquan Guo
Journal:  Front Pharmacol       Date:  2018-06-12       Impact factor: 5.810

6.  A novel nitidine chloride nanoparticle overcomes the stemness of CD133+EPCAM+ Huh7 hepatocellular carcinoma cells for liver cancer therapy.

Authors:  Danni Li; Qiying Zhang; Yuzhu Zhou; Hua Zhu; Tong Li; Fangkai Du
Journal:  BMC Pharmacol Toxicol       Date:  2022-07-12       Impact factor: 2.605

7.  New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules.

Authors:  Yu-Ru Lee; Dah-Shyong Yu; Ya-Chun Liang; Kuo-Feng Huang; Shih-Jie Chou; Tsung-Chih Chen; Chia-Chung Lee; Chun-Liang Chen; Shih-Hwa Chiou; Hsu-Shan Huang
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.